BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8760797)

  • 1. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
    Van Waes C; Monach PA; Urban JL; Wortzel RD; Schreiber H
    Tissue Antigens; 1996 May; 47(5):399-407. PubMed ID: 8795140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection.
    Akilesh S; Dudley ME; Eden PA; Roopenian DC
    J Immunol; 2001 Nov; 167(9):5143-9. PubMed ID: 11673526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
    Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
    J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
    Cohen PA; Cohen PJ; Rosenberg SA; Mulé JJ
    Cancer Res; 1994 Feb; 54(4):1055-8. PubMed ID: 7906197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
    Huang AY; Gulden PH; Woods AS; Thomas MC; Tong CD; Wang W; Engelhard VH; Pasternack G; Cotter R; Hunt D; Pardoll DM; Jaffee EM
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9730-5. PubMed ID: 8790399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcoma.
    Colombo MP; Rodolfo M; Parmiani G
    J Immunogenet; 1983 Aug; 10(4):337-40. PubMed ID: 6604758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
    Johnston JV; Malacko AR; Mizuno MT; McGowan P; Hellström I; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Mar; 183(3):791-800. PubMed ID: 8642283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas.
    Palladino MA; Srivastava PK; Oettgen HF; DeLeo AB
    Cancer Res; 1987 Oct; 47(19):5074-9. PubMed ID: 3497717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen.
    Naito K; Pellis NR; Kahan BD
    Cell Immunol; 1987 Sep; 108(2):483-94. PubMed ID: 3113743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.
    Levraud JP; Pannetier C; Langlade-Demoyen P; Brichard V; Kourilsky P
    J Exp Med; 1996 Feb; 183(2):439-49. PubMed ID: 8627157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.